Krystal Biotech to Present at William Blair Biotech Focus Conference 2022
July 06 2022 - 6:00AM
Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), the leader in
redosable gene therapy, announced today that the Company will
participate in the William Blair Biotech Focus Conference 2022
taking place in New York from July 12-13.
Krish Krishnan, Chairman and Chief Executive Officer, will
participate in a fireside chat during the conference and host
investor meetings on July 13.
A webcast of the event will be available here beginning at 9am
ET on July 11 and posted on the Investor section of the Company’s
website.
About Krystal Biotech, Inc.Krystal Biotech,
Inc. (NASDAQ: KRYS) is a pivotal-stage gene therapy company
leveraging its proprietary, redosable gene therapy platform and
in-house manufacturing capabilities to develop life-changing
medicines for patients with serious diseases, including rare
diseases in skin, lung, and other areas. For more information
please visit http://www.krystalbio.com, and follow @KrystalBiotech
on LinkedIn and Twitter.
CONTACTS:Investors and
Media:Meg DodgeKrystal Biotechmdodge@krystalbio.com
Source: Krystal Biotech, Inc.
Krystal Biotech (NASDAQ:KRYS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Krystal Biotech (NASDAQ:KRYS)
Historical Stock Chart
From Jul 2023 to Jul 2024